Top 10 Pharma CEO salaries of 2009
Welcome to to our annual look at the biggest CEO paychecks in the pharma industry. The major trend in 2009 was the mega-merger, which helped propel former Schering-Plough CEO Fred Hassan to the top of this year's list. With the help of a $33 million golden handshake, Hassan bypassed perennial top dogs Bill Weldon (Johnson & Johnson) and Miles White (Abbott) as the highest-paid CEO in Pharma.
Novartis' Daniel Vasella moved up three places to the number four spot this year, but it will be his last appearance on our CEO pay list. Vasella stepped down as chief of Novartis in January, and was replaced by Joe Jimenez. To discover more details for yourself--or to find out what your boss is making--take a look at the list below.
1. Fred Hassan - Schering-Plough - $49.65M
2. Bill Weldon - Johnson & Johnson - $30M
3. Miles White - Abbott Laboratories - $26.2M
4. John Lechleiter - Eli Lilly - $20.9M
5. Daniel Vasella - Novartis - $20.24M
6. Jim Cornelius - Bristol-Myers Squibb - $18.2M
7. Richard Clark - Merck - $16.8M
8. Robert Coury - Mylan - $16M
9. Jeffrey Kindler - Pfizer - $14.8M
10. Frank Baldino - Cephalon - $11.1M
Comments
Mr. Fred Hassan got rich with his operations (Buying Organon from Schring-Plough then selling everything to Merk). I lost my job at Organon in the first transaction. Today 2200 ex-colleagues from Research & Development in Oss (Holland) were told that will lose their job at new employer Merk.
Interesting world this one, where a guy can earn 50 million while thousands go to the street. More than 70 years of Dutch legacy evaporated...
The guy has form! I used to work for Pharmacia & Upjohn and saw similar behavior there BUT we have to remember that these guys are there to maximize payouts - not to the employees but shareholders and so they will do what they have to do to achieve that. No, I dont like it either but thats the way the system works. People are just conveniences - convenient to have them when you need them and just as convenient to discard them when you dont.
With all these people out of work due to mergers over the last few years, who is going to be able to buy the products made by these same companies?
Hello folks. My name is Capitalism, nice to meet you. Thought I'd introduce myself just in case you haven't heard of me. I've been the system behind the dynamics you are complaining about. It's not the CEOs' fault, it's not shareholders' fault, it's not employee's fault. Layoffs and cost cutting have been the reality of the business world for as long as I can remember, my friends. It's not all bad... it's how the United States have become a super-power after World War II, continuously raising productivity and generating innovation. Too bad for the people who don't help on either one of those two dimensions. If you're not helping your company increase productivity, you are effectively reducing its productivity. If you're not helping your company innovate and generate new revenues, you're just an incremental cost. And that's why your job is at risk.
Great Post. Too many people forget who we are and what business is about. While they get lost in altruistic ideas without realizing that it is the competitive nature markets that lead to more progress and improvements. Is Hassan worth the money? probably not but in a free market he has earned it.
yeah, but in the long run buying organon in 2007 to virtually divest of it in 2010 is short sighted. He should have just skipped the Organon deal and just Merged SP and Merck but that would not have made him as much money. Hassan made money for Hassan. The innovation was in brokering the deal. You won't see any innovative products from Merck.. the knowledge is in the people and you divest of people and go for safte me too drugs well where is the value?
"it is the competitive nature markets that lead to more progress and improvements" - yep, describes pharma perfectly. Hey I know, let me change this chlorine to a fluorine on this molecule. Doesn't do anything for efficacy, but we can give the drug a cool name, shoot a bunch of commercials for it, have our reps buy some dinners for a bunch of docs and hell, even make up fake diseases that the drug can treat. Yep, "progress and improvement" in the pharma industry!!!
Although what you say is accurate in principle, unfortunately the reality of things is that the practice you are talking about is also the downfall of the USA and the reason why it is struggling to remain as the superpower in this worldwide economy. Normally, as layoffs occur, new job opportunities arise either in peripheral or unrelated fields and folks are able to acquire employment which is either equal or better in remuneration than before they were laid off. This in turn allows them to be able to spend money, and that's what makes the wheels go round. Unfortunately, these days, when the layoffs come it usually to increase profit margins in a stagnant economy (i.e. folks can't really afford to buy anything), or avoid being dragged under due to slow sales and uncertain forecasts for upcoming pipeline of product. To add insult to injury, the work force that was laid off can't get back on a payroll because those jobs were sent off to countries where the labor is cheap. The end result is that folks here are left with no job, no money to buy anything, and poor prospects for getting back into the work force. The upside, is that if you are a top tier executive, you probably make great money as you are the one who is able to ensure the company's bottomline is constantly increasing. So the poor get poorer, and the rich get richer.
Even though there are always success stories, more and more it is getting increasingly harder and harder to come up with new concepts that you can build into an empire. Even if someone is able to do so, it's very likely that they either get bought out, or squeezed out.
Just as Communism in its pure form was doomed to fail, so is Capitalism. In either case, you end up with a work force that has very little incentive to work. With Communism, there is no reason to do anymore than you absolutely have to since you are not going to get more than your neighbor; in Capitalism, there is no reason to do anymore because no matter how much you work, your workload keeps on increasing, your free time keeps on decreasing, and your salary doesn't ever seem to meet inflation.
Maximize profits? How well have the pharmaceutical industry performed over the past 15 years. They have used a short term approach to profits, which help their options. Not the stock holders!
Bottom line...if the pharma CEOs can earn this type of money, we are charging to much for medications.
The Tea Party is being attacked because the Tea Party represents ordinary, hard working, Americans who usually don't have someone representing them. The "silent majority" is starting to speak-up through the Tea Party and there are others that don'y like this; so they attack. The Tea Party's members come from all walks of life... their common thread is that they are hard working Americans who love their country and want it back. They understand why there is no other country like this one... freedom.
I'm old enough to remember that lay-offs actually caused the stock price to go down. Everyone interpreted the lay-offs as meaning the executive management didn't know how to keep their business running. Oh how times, have changed. It is time for an employee, not investor, based economy.
You are all ignoring the FACT that we are in the midst of a recession nearly as catastrophic for the global financial system as the 1930s crash.
in these circumstances, American capitalism dictates (and I use the word advisedly) that the wealthy *bury* their assets and the rest go to the wall (social security handouts and begging).
It makes the behaviour of Japanese companies (to preserve domestic jobs as far as possible) during their ongoing prolonged recession look almost angelic.
PS to optimists: Look at history - 1) it will take about 20 years to recover from this serious recession, as the new gov in Britain is now predicting; and more worrying, 2) WWI erupted in similar circumstances once the fuse was lit (in the Balkans).
Hat-tip to Niall Ferguson: *The ascent of money*
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: